Fred Alger Management’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-60,055
Closed -$140K 497
2023
Q4
$140K Buy
+60,055
New +$140K ﹤0.01% 417